| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000038165 |
| Receipt No. | R000043502 |
| Scientific Title | Study on the effects of ingestion of water chestnut tea "Hishicha" on body fat |
| Date of disclosure of the study information | 2019/10/04 |
| Last modified on | 2020/04/01 (Ver. 4) |
| Basic information | ||
| Public title | Study on the effects of ingestion of water chestnut tea "Hishicha" on body fat | |
| Acronym | Effects of ingestion of Hishicha on body fat | |
| Scientific Title | Study on the effects of ingestion of water chestnut tea "Hishicha" on body fat | |
| Scientific Title:Acronym | Effects of ingestion of Hishicha on body fat | |
| Region |
|
|
| Condition | ||
| Condition | obesity | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effects of long-tern ingestion water chestnut tea "Hishicha" on suppression of body fat. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Visceral fat area |
| Key secondary outcomes | Height, Body weight, BMI, Body fat percentage, Waist length, Blood pressure, AGEs (Advanced Glycation End Products), Total bilirubin, Total protein, Albumin, AST, ALT, ALP, LD, gamma-GT, Total cholesterol, LDL-cholesterol, HDL-cholesterol, Serum triglyceride, Serum amylase, Urea nitrogen, Creatinine, Uric acid, Na, Cl, K, Direct bilirubin, CK, Cholinesterase, Calcium, Inorganic phosphorus, Serum blood glucose level, White blood cell count, Red blood cell count, Hemoglobin, Hematocrit, Platelet count, Hemoglobin A1c, Dietary survey |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | The subjects ingested the active meal for eight weeks. | |
| Interventions/Control_2 | The subjects ingested the placebo meal for eight weeks. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Individuals who live or work in Kanzaki city
2) Adults aged 20 to 70 (both male and female) 3) Individuals who are concerned about obesity or visceral fat 4) BMI {weight kg / (height m) 2 or more} is 23 or more and less than 30 5) As a rule, individuals with visceral fat area of 80 cm2 or more or waist length of 81 cm or more 6) Individuals who understand the purpose and contents of the experiment |
|||
| Key exclusion criteria | 1) Individuals who cannot meet the values of residence or work place, age, BMI, visceral fat area or waist circumference
2) Individuals using drugs that may affect lipid metabolism 3) Individuals who cannot stop taking supplements and health foods that may affect lipid metabolism during the test period 4) Individuals suffering from diabetes, kidney / liver disease or being treated 5) Individuals who have been diagnosed with primary dyslipidemia such as familial hypercholesterolemia 6) Individuals with chronic diseases who regularly use drugs 7) Individuals who cannot stop taking large amounts of green tea, oolong tea and black tea during the test period 8) Individuals who are pregnant, those who intend to become pregnant during the test period, breastfeeding individuals 9) Individuals taking part in other food intake and drug use tests, cosmetics and drug application tests 10) Other individuals whose doctors are deemed inappropriate as research subjects 11) Individuals who have been asked to cancel the clinical test |
|||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nishikyushu University | ||||||
| Division name | Faculty of Health and Nutrition Sciences | ||||||
| Zip code | 842-8585 | ||||||
| Address | 4490-9 Osaki, Kanzaki-machi, Kanzaki-shi, Saga, Japan | ||||||
| TEL | 0952-37-9274 | ||||||
| midori@nisikyu-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nishikyushu University | ||||||
| Division name | Faculty of Health and Nutrition Sciences | ||||||
| Zip code | 842-8585 | ||||||
| Address | 4490-9 Osaki, Kanzaki-machi, Kanzaki-shi, Saga, Japan | ||||||
| TEL | 0952-52-4191 | ||||||
| Homepage URL | |||||||
| midori@nisikyu-u.ac.jp | |||||||
| Sponsor | |
| Institute | Nishikyushu University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kanzaki-shi |
| Organization | |
| Division | |
| Category of Funding Organization | Local Government |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Nishikyushu University |
| Address | 4490-9 Osaki, Kanzaki-machi, Kanzaki-shi, Saga, Japan |
| Tel | 0952-52-4191 |
| midori@nisikyu-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 44 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000043502 |